• 11933 Citations
  • 53 h-Index
19962021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Primo N Lara is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 42 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2002 2021

CANCER CENTER SUPPORT GRANT-P30

DeGregorio, M., Matthews, D., Felton, J. S., deVere White, R. W., Radke, K., Lloyd, K. K., Gandara, D. R., Beckett, L. A., Gregg, J., Luciw, P. A., Kung, H., Gumerlock, P. H., Mack, P., Evans, C. P., Lara, P. N., Lam, K., Chen, X., Kelly, K., Cherry, S. R., Shacklett, B., Lloyd, K. C. K. & Chen, M.

National Institutes of Health

7/1/026/30/21

Project: Research project

Neoplasms
Organized Financing
Research
Research Personnel
Clinical Trials
Clinical Trials
Organizations
Neoplasms
Therapeutics
Contracts
Medical Oncology
Neoplasms
Research
Curriculum
Research Personnel
Bone Remodeling
Prostatic Neoplasms
Biomarkers
Bone and Bones
docetaxel
Clinical Trials
Neoplasms
Health Services Research
Communication
Research Personnel

Research Output 1996 2019

Considerations for the Next Clinical Trial Evaluating the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

Kim, H. L., Mayerson, E., Lara, P. N., Messing, E., Tangen, C., Shuch, B. M. & Vaishampayan, U., Jan 1 2019, In : European Urology Focus.

Research output: Contribution to journalComment/debate

Nephrectomy
Renal Cell Carcinoma
Clinical Trials
Immunotherapy
Therapeutics
2 Citations (Scopus)

Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer

Chen, W. S., Aggarwal, R., Zhang, L., Zhao, S. G., Thomas, G. V., Beer, T. M., Quigley, D. A., Foye, A., Playdle, D., Huang, J., Lloyd, P., Lu, E., Sun, D., Guan, X., Rettig, M., Gleave, M., Evans, C. P., Youngren, J., True, L., Lara, P. N. & 8 othersKothari, V., Xia, Z., Chi, K. N., Reiter, R. E., Maher, C. A., Feng, F. Y., Small, E. J. & Alumkal, J. J., Jan 1 2019, In : European Urology.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Catenins
Survival Analysis
Survival

Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer

Heath, E., Heilbrun, L., Mannuel, H., Liu, G., Lara, P. N., Monk, J. P., Flaig, T., Zurita, A., Mack, P., Vaishampayan, U., Stella, P., Smith, D., Bolton, S., Hussain, A., Al-Janadi, A., Silbiger, D., Usman, M. & Ivy, S. P., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

Open Access
docetaxel
Prednisone
Multicenter Studies
Prostatic Neoplasms
Drug Therapy
1 Citation (Scopus)
Open Access
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Neoplasms
Mutation

Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity

Aggarwal, R. R., Quigley, D. A., Huang, J., Zhang, L., Beer, T. M., Rettig, M. B., Reiter, R. E., Gleave, M. E., Thomas, G. V., Foye, A., Playdle, D., Lloyd, P., Chi, K. N., Evans, C. P., Lara, P. N., Feng, F. Y., Alumkal, J. J. & Small, E. J., Jun 1 2019, In : Molecular cancer research : MCR. 17, 6, p. 1235-1240 6 p.

Research output: Contribution to journalArticle

Neuroendocrine Carcinoma
Neuroendocrine Cells
Small Cell Carcinoma
Prostatic Neoplasms
Genome